Phase II trial of fludarabine alternating with interferon (IFN)alpha 2B in low grade non-Hodgkin's lymphoma (NHL)

被引：0
|
作者：
Smith, MR
Boyd, RL
Minnitti, C
Clyde, J
Hoessly, MC
Cornfeld, M
Yeslow, G
Halbherr, T
Rogatko, A
Schilder, RJ
Young, RC
Millenson, MM
机构：
[1] FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
[2] FOX CHASE NETWORK,PHILADELPHIA,PA 19111
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：861 / 861
页数：1
相关论文
共 50 条
  • [41] Phase II multicenter trial of pentostatin and rituximal in patients with previously treated and untreated non-Hodgkin's lymphoma (NHL)
    Yunus, F
    George, S
    Smith, J
    Geils, G
    Geils, G
    BLOOD, 2003, 102 (11) : 642A - 643A
  • [42] Comparative economic analysis of the treatment of relapsed low grade B-cell non-Hodgkin's lymphoma (NHL) in France using chop, fludarabine or rituximab.
    Omnes, LF
    Foutel, V
    Haioun, C
    Jasso-Mosqueda, G
    Mathieu-Boue, A
    Hieke, K
    Kerrigan, M
    BLOOD, 1999, 94 (10) : 96A - 96A
  • [43] A phase II study of mitoxantrone and fludarabine followed by anti-CD20 monoclonal in the treatment of patients with previously untreated low grade non-Hodgkin's lymphoma (LG-NHL).
    Gregory, SA
    Venugopal, P
    Adler, SS
    O'Brien, TM
    O'Donnell, KF
    Subramanian, A
    Robin, EL
    BLOOD, 2000, 96 (11) : 732A - 732A
  • [44] A PHASE II TRIAL OF THE ORAL MTOR INHIBITOR EVEROLIMUS IN RELAPSED NON-HODGKIN LYMPHOMA (NHL) AND HODGKIN DISEASE (HD)
    Witzig, E.
    Habermann, T.
    Reeder, C.
    Micallef, I.
    Ansell, S.
    Porrata, L.
    Johnston, P.
    LaPlant, B.
    Kabat, B.
    Zent, C.
    Zeldenrust, S.
    Inwards, D.
    Colgan, J.
    Call, T.
    Markovic, S.
    Tun, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 436 - 436
  • [45] Chemoimmunotherapy with Fludarabine, Bendamustine and Rituximab for relapsed low grade malignant Non-Hodgkin's Lymphoma.
    Kirchner, HH
    Gaede, B
    Steinhauer, EU
    Panagiotou, P
    Sosada, M
    BLOOD, 2001, 98 (11) : 135A - 135A
  • [46] Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma
    Misgeld, E
    Germing, U
    Aul, C
    Gattermann, N
    LEUKEMIA RESEARCH, 2001, 25 (01) : 95 - 98
  • [47] Phase I/II study of fractionated radioimmunotherapy (RIT) in relapsed low grade non Hodgkin's lymphoma (NHL).
    Bayne, M
    Zivanovic, M
    Lewington, V
    Du, Y
    Harrison, C
    Hodges, L
    Johnson, P
    Illidge, T
    BRITISH JOURNAL OF CANCER, 2003, 88 : S38 - S38
  • [48] Rituxan plus GM-CSF for the treatment of low grade follicular (B cell) non-Hodgkin's lymphoma (NHL).
    Janakiraman, N
    Gautam, S
    Xu, Y
    Fortney, C
    Green, J
    van derVeen, M
    Looney, S
    Carey, JL
    BLOOD, 2001, 98 (11) : 243B - 243B
  • [49] FLUDARABINE IN RELAPSED LOW-GRADE NON-HODGKIN LYMPHOMAS - A PHASE-II STUDY OF THE GERMAN LOW-GRADE LYMPHOMA STUDY-GROUP
    POTT, C
    UNTERHALT, M
    SANDFORD, D
    MARKERT, H
    FREUND, M
    ENGERT, A
    GASSMANN, W
    HOLTKAMP, W
    SEUFERT, M
    HELLRIEGEL, K
    KNAUF, B
    NIEBERDING, R
    EMMERICH, B
    KOCH, P
    WORMANN, B
    HIDDEMANN, W
    BLOOD, 1993, 82 (10) : A575 - A575
  • [50] Phase II study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma
    Tobinai, K
    Watanabe, T
    Ogura, M
    Morishima, Y
    Ogawa, Y
    Ishizawa, KI
    Minami, H
    Utsunomiya, A
    Taniwaki, M
    Terauchi, T
    Nawano, S
    Matsusako, M
    Matsuno, Y
    Nakamura, S
    Mori, S
    Ohashi, Y
    Hayashi, M
    Seriu, T
    Hotta, T
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) : 174 - 180
12345